pindolol has been researched along with Arrhythmias, Cardiac in 61 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lorcainide, a new class I antiarrhythmic agent, was administered intravenously to eight patients with acute myocardial infarction for 24 hours, and thereafter given by mouth, 200 mg daily for ten days." | 9.05 | Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. ( Gordin, A; Heikkilä, J; Leinonen, H; Sundberg, S, 1984) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Viskén) combined with hydralazine." | 9.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1976) |
| "The effect of pindolol on experimental myocardial infarction was studied in a pig model." | 7.67 | Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig. ( Althaus, U; Friedli, HP; Gurtner, HP; Magnenat, L, 1986) |
| "The role of pindolol in treating ventricular arrhythmia was studied in 43 patients with this disorder." | 7.66 | Pindolol for ventricular arrhythmia. ( Lown, B; Podrid, PJ, 1982) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 7.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| "In this study the anti-arrhythmic effectiveness of pindolol has been tested on ventricular effort arrhythmias in a group of 22 cardiopathic patients." | 7.66 | [Pindolol in the treatment of arrhythmias caused by exertion]. ( Giordano, A; Rossi, P; Schiavo, B; Tamiz, A, 1979) |
| "A study was designed to examine ventricular arrhythmias in the acute phase of experimental myocardial infarction in the pig and to evaluate possible antiarrhythmogenic influence of the beta-adrenergic blocking drug pindolol (Visken) and the calcium antagonist Ro 11-1781." | 7.66 | [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781]. ( Althaus, U; Dolder, M; Frank, J; Gertsch, M; Gurtner, HP, 1978) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 7.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| " Ambulatory electrocardiography was used to compare the effects of propranolol and pindolol on symptoms, heart rate, arrhythmias and ST segments." | 5.06 | The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography. ( Ballantyne, D; Northcote, RJ, 1988) |
| "Lorcainide, a new class I antiarrhythmic agent, was administered intravenously to eight patients with acute myocardial infarction for 24 hours, and thereafter given by mouth, 200 mg daily for ten days." | 5.05 | Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. ( Gordin, A; Heikkilä, J; Leinonen, H; Sundberg, S, 1984) |
| "Thirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and pindolol (Viskén) combined with hydralazine." | 5.04 | Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. ( Persson, I, 1976) |
| "The effect of pindolol on experimental myocardial infarction was studied in a pig model." | 3.67 | Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig. ( Althaus, U; Friedli, HP; Gurtner, HP; Magnenat, L, 1986) |
| "Combination of the beta-adrenergic blocking agent visken with glucagon in the acute period of myocardial infarction possesses higher antiarrhythmic activity with a negligible cardiodepressive effect as compared to that of isolated administration of visken and leads to a decrease in the excessive production of catecholamines and glucocorticoids in the blood." | 3.66 | [Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct]. ( Golikov, AP; Ivleva, VI; Orlov, AI; Stepura, OB, 1980) |
| " However, in vitro experiments are not satisfactory to predict antiarrhythmic activity "in vivo", because: 1) they are mostly performed in preparations made from the normal myocardium; 2) "in vitro" the autonomic and hormonal effects are absent; 3) some drugs as nitroglycerin or strophanthin do not produce antiarrhythmic electrophysiological changes in "vitro" but under appropriate conditions they may have a clear-cut antiarrhythmic action "in vivo"; 4) arrhythmias mostly arise from the interaction of changes in several fundamental electrophysiological parameters which could be best studied "in vivo"." | 3.66 | [Pharmacologic evaluation of electrical processes in the myocardium]. ( Sekeresh, L, 1982) |
| " Lidocaine and pindolol pretreatment increased the survival rate and attenuated the life-threatening arrhythmias during the first 20 min, but did not influence the infarct size 16 hrs later." | 3.66 | Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. ( Koltai, M; Leprán, I; Siegmund, W; Szekeres, L, 1983) |
| "The role of pindolol in treating ventricular arrhythmia was studied in 43 patients with this disorder." | 3.66 | Pindolol for ventricular arrhythmia. ( Lown, B; Podrid, PJ, 1982) |
| "The study was designed to assess the antiarrhythmic and antianginal properties of pindolol as well as the tolerance to the drug by patients who had experienced a myocardial infarction 5 to 6 months previously." | 3.66 | Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity. ( Roskamm, N; Samek, L; Sturzenhofecker, P; Welzel, D, 1982) |
| "In this study the anti-arrhythmic effectiveness of pindolol has been tested on ventricular effort arrhythmias in a group of 22 cardiopathic patients." | 3.66 | [Pindolol in the treatment of arrhythmias caused by exertion]. ( Giordano, A; Rossi, P; Schiavo, B; Tamiz, A, 1979) |
| "To evaluate the ability of histamine to induce ventricular arrhythmias, we studied the effects of histamine on ventricular rhythmicity in the isolated guinea pig heart with complete atrioventricular conduction block." | 3.66 | Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors. ( Levi, R; Zavecz, JH, 1979) |
| "A study was designed to examine ventricular arrhythmias in the acute phase of experimental myocardial infarction in the pig and to evaluate possible antiarrhythmogenic influence of the beta-adrenergic blocking drug pindolol (Visken) and the calcium antagonist Ro 11-1781." | 3.66 | [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781]. ( Althaus, U; Dolder, M; Frank, J; Gertsch, M; Gurtner, HP, 1978) |
| "The authors report four new cases of hyperthyroidism associated with prolonged treatment with amiodarone." | 3.65 | [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases]. ( Chapelle, M; Naouri, R; Wolff, F, 1976) |
| "The utility of using beta blocking drugs, specifically Pindolol, as a prophylaxis for arrhythmia during cardiac microcatheterism according to Grandjean's technique has been observed." | 3.65 | [Prevention of arrhythmias during heart catheterization]. ( Di Napoli, T; di Quacquaro, GS; Giovine, F; Monaco, G, 1977) |
| "Oxprenolol or pindolol were used as primary drugs in 8 cases." | 1.26 | [Therapy of postoperative arrhythmias (author's transl)]. ( Vormittag, E, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (93.44) | 18.7374 |
| 1990's | 3 (4.92) | 18.2507 |
| 2000's | 1 (1.64) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groszek, G | 1 |
| Bednarski, M | 1 |
| Dybała, M | 1 |
| Filipek, B | 1 |
| Golikov, AP | 2 |
| Orlov, AI | 2 |
| Ivleva, VI | 1 |
| Stepura, OB | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| Vaniev, SB | 1 |
| Berestov, AA | 1 |
| Maĭorov, NI | 1 |
| Frishman, WH | 2 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Leinonen, H | 1 |
| Heikkilä, J | 1 |
| Sundberg, S | 1 |
| Gordin, A | 1 |
| Sekeresh, L | 1 |
| Leprán, I | 1 |
| Koltai, M | 1 |
| Siegmund, W | 1 |
| Szekeres, L | 2 |
| Podrid, PJ | 1 |
| Lown, B | 1 |
| Welzel, D | 1 |
| Roskamm, N | 1 |
| Samek, L | 2 |
| Sturzenhofecker, P | 1 |
| Roskamm, H | 1 |
| Satoh, H | 1 |
| Hisatome, I | 1 |
| Arita, M | 1 |
| Zamotaev, IP | 2 |
| Lozinskiĭ, LG | 2 |
| Sandomirskiĭ, BL | 2 |
| Maksimova, LN | 1 |
| Erding, E | 1 |
| Nalbantgil, E | 1 |
| Kiliccioglu, B | 1 |
| Nalbantgil, I | 1 |
| Vidinel, I | 1 |
| Frishman, W | 1 |
| Davis, R | 1 |
| Strom, J | 1 |
| Elkayam, U | 1 |
| Stampfer, M | 1 |
| Ribner, H | 1 |
| Weinstein, J | 1 |
| Sonnenblick, E | 1 |
| Giordano, A | 1 |
| Tamiz, A | 1 |
| Schiavo, B | 1 |
| Rossi, P | 1 |
| Vormittag, E | 1 |
| Doshchitsin, VL | 1 |
| Frisch, P | 1 |
| Levi, R | 1 |
| Zavecz, JH | 1 |
| Frank, J | 1 |
| Dolder, M | 1 |
| Gertsch, M | 1 |
| Althaus, U | 2 |
| Gurtner, HP | 2 |
| Persson, I | 1 |
| Chapelle, M | 1 |
| Naouri, R | 1 |
| Wolff, F | 1 |
| di Quacquaro, GS | 1 |
| Giovine, F | 1 |
| Di Napoli, T | 1 |
| Monaco, G | 1 |
| Zdichynec, B | 1 |
| Dubova, MN | 1 |
| Zisel'man, SB | 1 |
| Pankratov, AB | 1 |
| Offenstadt, G | 1 |
| Hericord, PH | 1 |
| Amstrutz, PH | 1 |
| Latorre, A | 1 |
| Lenti, M | 1 |
| Calabrese, P | 1 |
| Miyazaki, M | 1 |
| Nioka, S | 1 |
| Fujita, T | 1 |
| Koaté, P | 1 |
| Diouf, S | 1 |
| Diouf, D | 1 |
| Essalai, M | 1 |
| Santini, M | 1 |
| Dini, P | 1 |
| Di Mascolo, R | 1 |
| Milazzotto, F | 1 |
| Jacovella, G | 1 |
| Molenaar, P | 1 |
| Russell, FD | 1 |
| Shimada, T | 1 |
| Summers, RJ | 1 |
| Sugiyama, S | 1 |
| Hattori, M | 1 |
| Miyazaki, Y | 1 |
| Nagai, S | 1 |
| Ozawa, T | 1 |
| Northcote, RJ | 1 |
| Ballantyne, D | 1 |
| Knüttgen, D | 1 |
| Doehn, M | 1 |
| Friedli, HP | 1 |
| Magnenat, L | 1 |
| Oulhaci, M | 1 |
| Merad, B | 1 |
| Toumi, N | 1 |
| Ait-Amar, M | 1 |
| Boudjellab, A | 1 |
| Issad, M | 1 |
| Piva, G | 1 |
| Färber, A | 1 |
| Kenedi, I | 1 |
| Losonci, A | 1 |
| Gross, F | 1 |
| Bhargava, KP | 1 |
| Gupta, MC | 1 |
| Mathur, KS | 1 |
| Dalal, S | 1 |
| Maruyama, S | 1 |
| Ducloux, M | 1 |
| Singh, BN | 2 |
| Offerhaus, L | 1 |
| Jewitt, DE | 1 |
| Goch, JH | 1 |
| Damany, SJ | 1 |
| Bhatt, GR | 1 |
| Tikare, SK | 1 |
| Thaly, KG | 1 |
| Gupta, PS | 1 |
| Bisht, DB | 1 |
| Banerji, K | 1 |
| Chaubey, BS | 1 |
| Attal, HC | 1 |
| Pretolani, E | 1 |
| Zoli, I | 1 |
| Addarii, F | 1 |
| Meier, J | 1 |
| Baranowski, E | 1 |
| Wagner, E | 1 |
| Waucampt, JJ | 1 |
| Decalf, A | 1 |
| Delmon, A | 1 |
| Goethals, S | 1 |
| Pauchant, M | 1 |
| Somani, P | 1 |
| Kumakura, S | 1 |
7 reviews available for pindolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity.
Topics: Animals; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Child; Coronary Disease; Female; Human | 1983 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
10 trials available for pindolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Clinical Tria | 1984 |
[Comparative evaluation of the clinical action of a series of beta-adrenergic blockaders].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Bronchi; Clinical Trials as Topi | 1976 |
[Prevention by pindolol of electrocardiographic changes during bronchoscopy performed under local and general anesthesia].
Topics: Adult; Aged; Anesthesia, Inhalation; Anesthesia, Local; Arrhythmias, Cardiac; Bronchoscopy; Drug Eva | 1977 |
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydr | 1976 |
[Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Tri | 1985 |
The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Electrocardiography; Heart Rate; Humans; Male; M | 1988 |
[Pindolol in intraoperatively developing isorhythmic AV dissociation].
Topics: Adult; Arrhythmias, Cardiac; Atrioventricular Node; Electrocardiography; Female; Heart Conduction Sy | 1987 |
Visken (LB-46) a double blind cross-over study in cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Humans; Hyperthyroidism; Pindolol; Placebos; Propran | 1972 |
A new beta-adrenergic blocking agent in cardiac arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Female; Humans; Hyperthyroidism; Male; Middle Aged; Pindolol; Pla | 1972 |
45 other studies available for pindolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
Topics: 2-Propanol; Adrenergic Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroca | 2009 |
[Anti-arrhythmic and hemodynamic effects of visken and glucagon in rhythm disorders in the acute phase of myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamin | 1980 |
[Use of beta-adrenoblockaders in the therapy of the syndromes accompanying acute myocardial infarct].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Hemodynamics; Humans | 1981 |
[Pharmacologic evaluation of electrical processes in the myocardium].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Evaluation | 1982 |
Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Disease Models, Animal; Lidocaine | 1983 |
Pindolol for ventricular arrhythmia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Evaluation; Exercise Test; Female; Heart Ventricles; Humans; | 1982 |
Pindolol postmyocardial infarction study: evaluation of the drug's antiarrhythmic and antianginal activity.
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Drug Evaluation; Exercise Test; Heart Rate; Humans; Mi | 1982 |
Antianginal and antiarrhythmic effects of pindolol in post-infarct patients.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Heart Rate; Humans; Myocardial Infarction; Physical Exertion; | 1982 |
Modulation of the automaticity by histamine and cimetidine in rabbit sino-atrial node cells.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cell Membrane; Cimetidine; Electrophysiology; Hear | 1993 |
Effects of catecholamines on the residual sodium channel dependent slow conduction in guinea pig ventricular muscles under normoxia and hypoxia.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels; Catecholamines; Dose-Response Re | 1995 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Bronchial Spas | 1979 |
[Pindolol in the treatment of arrhythmias caused by exertion].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Humans; Male; Middle Aged; Pindolol | 1979 |
[Therapy of postoperative arrhythmias (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complex | 1979 |
[Comparative evaluation of new drugs used in the treatment of cardiac arrhythmia].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Ajmaline; Alprenolol; Anti-Arrhythmia Agents; Arr | 1975 |
Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors.
Topics: Anaphylaxis; Animals; Arrhythmias, Cardiac; Chlorpheniramine; Cimetidine; Dose-Response Relationship | 1979 |
[Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781].
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Calcium; Female; Myocardial Infarction; Pindolol; Swin | 1978 |
[Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases].
Topics: Adult; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Electrocardiography; Female; | 1976 |
[Prevention of arrhythmias during heart catheterization].
Topics: Arrhythmias, Cardiac; Cardiac Catheterization; Heart Rate; Humans; Pindolol | 1977 |
[Treatment of supraventricular arrhythmias using the beta-blockader Visken].
Topics: Arrhythmias, Cardiac; Blood Pressure; Female; Heart Rate; Heart Ventricles; Humans; Male; Pindolol | 1977 |
[Use of beta adrenergic receptor blockaders in the early postoperative period].
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Evaluation; Humans; Middle Aged; Oxprenolol; Pindolol; Posto | 1977 |
[Letter: Voluntary poisoning with pindolol].
Topics: Adult; Arrhythmias, Cardiac; Coma; Female; Humans; Hypertension; Pindolol; Substance-Related Disorde | 1976 |
[LB-46 in the treatment of angina pectoris, arrhythmia and functional cardiac disorders].
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Female; | 1976 |
[Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
Topics: Adult; Alprenolol; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Enflurane; Halothane | 1975 |
[Use of a beta blocker--the LB 46--in the treatment of certain arrhythmias].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Drug Evaluation; Female; Humans; Male; Middle Aged; Pindolo | 1975 |
[Effects of pindolol on the automatism of the sinus node and on atrioventricular and intraventricular conduction in man].
Topics: Arrhythmias, Cardiac; Atrioventricular Node; Bundle of His; Female; Heart Conduction System; Humans; | 1975 |
Densitometric analysis of beta 1- and beta 2-adrenoceptors in guinea-pig atrioventricular conducting system.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Autoradiography; | 1990 |
Mechanism of antiarrhythmic action of beta-blocking agents.
Topics: Acebutolol; Acyl Coenzyme A; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Ca | 1985 |
Cardioprotection by anti-ischaemic and cytoprotective drugs.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden; Dietary Fats; Epoprostenol; Humans; | 1987 |
Effects of pindolol therapy on the size of experimentally induced myocardial infarction in the pig.
Topics: Animals; Arrhythmias, Cardiac; Female; Hemodynamics; Myocardial Infarction; Pindolol; Swine | 1986 |
[A new beta-blocker, LB 46--Visken].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Heart Defects, Congenital; Huma | 1973 |
[Treatment of tachycardias and arrhythmias. Studies using Visken].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Coronary Di | 1974 |
Effect of beta adrenergic blocking on the arrhythmias following coronary ligation in rat.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmia, Sinus; Arrhythmias, Cardiac; Cardiac Complexes, Pr | 1973 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
On the importance of a central beta-adrenoceptor site in the antiarrhythmic activity of beta-blockers.
Topics: Aconitum; Adrenal Glands; Adrenergic beta-Antagonists; Alprenolol; Animals; Arrhythmias, Cardiac; Ca | 1972 |
Anti-arrhythmic effects of LB-46 on experimentally produced digitoxic arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Digoxin; Dogs; Female; Male; Pindolol | 1972 |
Electrophysiological evidence of the initiation of arrhythmia by beta-adrenergic blocking agents.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Dogs; Female; Heart C | 1973 |
[Pindolol in foreign medical practice].
Topics: Adrenergic beta-Antagonists; Adult; Africa, Northern; Angina Pectoris; Arrhythmias, Cardiac; Arterio | 1973 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Fail | 1973 |
[Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Arrhythmias, Cardiac; Evaluation S | 1972 |
LB-46 in cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Female; Heart Rate; Hum | 1972 |
Treatment of digitalis induced arrhythmias with LB-46 (Visken).
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Digitalis Glycosides; Electrocardiography; Female; Hu | 1972 |
[Pharmacological treatment associated with the insertion of a demand pacemaker in the atrial rhythm disease. Prearranged commentary on the report of Scardi and collaborators].
Topics: Ajmaline; Arrhythmias, Cardiac; Electrocardiography; Glucagon; Heart Block; Humans; Pacemaker, Artif | 1973 |
[Experimental studies on the cardio-selectivity of pindolol. Studies on healthy subjects, and patients with bronchitis and asthma].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Asthma; Bronchitis; Heart; Humans; Metaproterenol; Pindolol; | 1973 |
[Visken. Study of its action on atrial rhythm disorders and on chronic insufficiency. Apropos of 50 cases].
Topics: Adult; Angina Pectoris; Arrhythmias, Cardiac; Drug Evaluation; Heart Atria; Humans; Middle Aged; Pin | 1973 |
Anti-arrhythmic action of beta-adrenergic receptor blocking agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Dogs | 1973 |